Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands

Anna Lutkajtis, Jules Evans

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (57)

  1. Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness 2023-11-16 · Expand citations
  2. Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants. 2022-06-01 · Expand citations
  3. Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands 2021-04-16 · Expand citations
  4. Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
  5. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. 2020-04-01 · Expand citations
  6. Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. 2018-07-01 · Expand citations
  7. Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder. 2018-01-01 · Expand citations
  8. Long-term follow-up of psilocybin-facilitated smoking cessation. 2017-01-01 · Expand citations
  9. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  10. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  11. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. 2016-12-01 · Expand citations
  12. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. 2016-12-01 · Expand citations
  13. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  14. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  15. OpenAlex W2014087423
  16. OpenAlex W2129290879
  17. OpenAlex W2152723462
  18. OpenAlex W2171085033
  19. OpenAlex W2394818911
  20. OpenAlex W2417876543
  21. OpenAlex W2589381868
  22. OpenAlex W2620252718
  23. OpenAlex W275929455
  24. OpenAlex W2808647788
  25. OpenAlex W3014759361
  26. OpenAlex W3018943978
  27. OpenAlex W3083797211
  28. OpenAlex W3093676138
  29. OpenAlex W3139397908
  30. OpenAlex W3140493070
  31. OpenAlex W3149986569
  32. OpenAlex W3166553838
  33. OpenAlex W3173955184
  34. OpenAlex W3188608552
  35. OpenAlex W3215235944
  36. OpenAlex W3217718387
  37. OpenAlex W4210376981
  38. OpenAlex W4225336626
  39. OpenAlex W4229983790
  40. OpenAlex W4234286744
  41. OpenAlex W4236038590
  42. OpenAlex W4237438695
  43. OpenAlex W4247937382
  44. OpenAlex W4249610630
  45. OpenAlex W4285201277
  46. OpenAlex W4285890909
  47. OpenAlex W4289745468
  48. OpenAlex W4309139242
  49. OpenAlex W4376568678
  50. OpenAlex W4387589359
  51. OpenAlex W4396793804
  52. OpenAlex W565441131
  53. OpenAlex W648645029
  54. OpenAlex W6681014339
  55. OpenAlex W6754238388
  56. OpenAlex W6795936701
  57. OpenAlex W6810584516

Cited by — these papers cite this paper (5)

  1. Participant experiences and recommendations for psychedelic clinical trials and future treatment delivery: a qualitative study with experts by experience from the Psychedelic Participant Advocacy Network 2026-10-14 · Expand citations
  2. Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects 2025-11-30 · Expand citations
  3. Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey 2025-04-22 · Expand citations
  4. Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy 2024-10-09 · Expand citations
  5. The Psychedelic Social Club: a regulatory concept for people who use psychedelics? 2023-10-30 · Expand citations